with one milestone for cash and the other, equity in Axol Bioscience. “This ensured the seller is tied in post-acquisition and has ‘skin in the game’ to guarantee alignment on key risks post ...

This proposed structure would allow the Company to enhance its production capabilities and operational efficiency while preserving cash, without affecting current market trading conditions. "This ...